MarketWatch.com - Top Stories
GSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than £3 billion ($3.8 billion) met their goals.
Financial challenges face the next U.S. president — but one candidate’s remedies would be a ‘train wreck.’
Palo Alto Networks still is dealing with investor chagrin about the big shift in strategy it announced last quarter, in an effort to eventually boost revenue growth.
The former New York mayor-turned-Donald Trump attorney has launched Rudy Coffee. Marketing experts weigh in on his chance to succeed.
Ailing Peloton Interactive Inc. said late Monday it will issue convertible bonds as part of a debt swap, sending the fitness company’s stock 3.3% lower in the after-hours session.
Apple’s hardware events are usually most exciting to investors. But this time, Wall Street is highly anticipating the company’s annual software preview.
Construisez votre propre fil d'actualité
Prêt à tenter le coup ?
Commencer un essai de 14 jours, aucune carte de crédit n'est requise.